Related Experiment Video
Updated: Jun 1, 2026

Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Alternatively spliced tissue factor pathway inhibitor: functional implications
1Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201-2178, USA. alan.mast@bcw.edu
Abstract:
Tissue factor pathway inhibitor (TFPI) is a factor Xa dependent inhibitor of tissue factor initiated blood coagulation. In recent years several alternatively spliced forms of TFPI have been identified. These alternatively spliced forms have different C-terminal regions and have different mechanisms for association with cell surfaces. They are differentially expressed in human and mouse tissues and may have distinct physiological functions.
Insights
Tissue factor pathway inhibitor (TFPI) regulates blood clotting. Newly identified alternatively spliced TFPI forms exhibit varied cell surface interactions and tissue expression, suggesting distinct physiological roles in coagulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Tissue factor pathway inhibitor (TFPI) is a key regulator of the extrinsic pathway of blood coagulation.
- TFPI functions as a factor Xa-dependent inhibitor of the tissue factor/factor VIIa complex.
- The coagulation cascade is a complex system essential for hemostasis.
Purpose of the Study:
- To investigate the existence and characteristics of alternatively spliced forms of TFPI.
- To explore the functional implications of these different TFPI variants.
- To understand the differential expression and cell association mechanisms of TFPI isoforms.
Main Methods:
- Identification of alternatively spliced transcripts using molecular biology techniques.
- Analysis of C-terminal regions and cell surface association mechanisms.
- Differential expression studies in human and mouse tissues.
Main Results:
- Several alternatively spliced forms of TFPI have been identified.
- These variants possess distinct C-terminal regions.
- Differential expression patterns were observed across various tissues.
Conclusions:
- Alternatively spliced TFPI forms represent a novel layer of coagulation regulation.
- Variations in C-terminal regions likely influence TFPI localization and function.
- Distinct tissue expression suggests specialized physiological roles for TFPI isoforms in hemostasis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis
Regulation of Angiogenesis and Blood Supply
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

